M. Argyraki

The impact of metformin therapy on hepatic glucose production and skeletal muscle glycogen synthase activity in overweight type II diabetic patients

A.B. Johnson, J.M. Webster, Chee Fang Sum et al. · Metabolism · 1993 · 147 citations

Obesity, Metabolic Syndrome, Diabetes Management +12

Effect of increased free fatty acid supply on glucose metabolism and skeletal muscle glycogen synthase activity in normal man

A.B. Johnson, M. Argyraki, Jonathan Thow et al. · Clinical Science · 1992 · 78 citations

Metabolic Disorder, Intralipid Infusion, Insulin Signaling +19

Insulin-like and insulin-inhibitory effects of monoclonal antibodies for different epitopes on the human insulin receptor

Richard Taylor, Maria A. Soos, Alan Wells et al. · Biochemical Journal · 1987 · 68 citations · Full text

Immunology, Immunotherapy, Insulin Signaling +21

Impaired activation of skeletal muscle glycogen synthase in non-insulin-dependent diabetes mellitus is unrelated to the degree of obesity

A.B. Johnson, M. Argyraki, Jonathan Thow et al. · Metabolism · 1991 · 44 citations

Obesity, Metabolic Syndrome, Biochemistry +12

In vitro study of human skeletal muscle strips: Effect of nonesterified fatty acid supply on glucose storage

M. Argyraki, Peter Wright, C W Venables et al. · Metabolism · 1989 · 34 citations

Metabolic Syndrome, Body Composition, Skeletal Muscle +9